Monique A. Verstegen
Rotterdam, ZH 3015GD, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Modeling hepatocellular carcinoma and its microenvironment on a chip.
Journal: Cell death discovery
Published: July 15, 2025
Functional characterization of BAP1 mutations in genome edited cholangiocarcinoma organoids: Role in cell death and drug responses.
Journal: iScience
Published: July 07, 2025
Apoptosis regulators of the Bcl-2 family play a key role in chemoresistance of cholangiocarcinoma organoids.
Journal: International journal of cancer
Published: December 03, 2024
Targeting EIF4A1 is effective against human intrahepatic cholangiocarcinoma.
Journal: JHEP reports : innovation in hepatology
Published: June 26, 2024
Modelling metastatic colonization of cholangiocarcinoma organoids in decellularized lung and lymph nodes.
Journal: Frontiers in oncology
Published: November 18, 2022
Human branching cholangiocyte organoids recapitulate functional bile duct formation.
Journal: Cell stem cell
Published: October 21, 2021
The biological process of lysine-tRNA charging is therapeutically targetable in liver cancer.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 04, 2020
Prime editing for functional repair in patient-derived disease models.
Journal: Nature communications
Published: May 30, 2020
Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Journal: Cellular and molecular gastroenterology and hepatology
Published: March 15, 2020
Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth.
Journal: Cells
Published: December 20, 2019
LGR5 marks targetable tumor-initiating cells in mouse liver cancer.
Journal: Nature communications
Published: January 24, 2019
Last Updated: 09/26/2026